Company news
Shenzhen Yhlo Biotech Co. Ltd. Class A (SSE:688575) news
Shenzhen Yhlo Biotech Co. Ltd. Class A news releases on 6ix. Latest, Sep 22, 2026: "Shenzhen YHLO Biotech Co., Ltd."Announcement on Vesting Results…
Press releases & updates
"Shenzhen YHLO Biotech Co., Ltd."Announcement on Vesting Results for the Second Vesting Period (Second Batch) under the 2023 Restricted Share Incentive Plan and Listing of Shares
September 21, 2026
"Shenzhen YHLO Biotech Co., Ltd."Self-inspection Report on Trading in the Company's Shares by Insiders and Incentive Participants in Relation to the 2026 Restricted Share Incentive Plan
September 15, 2026
"Shenzhen YHLO Biotech Co., Ltd."Announcement on Resolutions of the 3rd Extraordinary General Meeting in 2026
September 14, 2026
"Shenzhen YHLO Biotech Co., Ltd."Statement and Review Opinion on the Public Disclosure of the List of Participants for the Initial Grant under the Company's 2026 Restricted Share Incentive Plan Issued by the Remuneration and Appraisal Committee of the Board of Directors
September 7, 2026
"Shenzhen YHLO Biotech Co., Ltd."Notice on Convening the 3rd Extraordinary General Meeting in 2026
August 26, 2026
"Shenzhen YHLO Biotech Co., Ltd."Announcement on Voluntary Disclosure of Obtaining Medical Device Registration Certificate
July 29, 2026
"Shenzhen YHLO Biotech Co., Ltd."Announcement on Providing Guarantees for Wholly-owned Subsidiaries
July 24, 2026
Indicative Announcement on Equity Change of Holding Shareholders, Actual Controller and Chairman and Persons Acting in Concert Reaching an Integer Multiple of 1%
June 17, 2026
Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2026
June 15, 2026
Announcement on Share Increase Plan of Controlling Shareholder, Actual Controller and Chairman
June 8, 2026
Announcement on Implementation of Dividend Distribution for 2025
June 5, 2026
Announcement on Obtaining Job Training Certificate and Official Assumption of Duties by Secretary of the Board of Directors
June 2, 2026
Announcement on the Deliberation of the External Donation Amount
May 29, 2026
Announcement on Resolutions of the 2025 Annual General Meeting
May 21, 2026
Announcement on Appointment of Secretary of the Board of Directors
May 13, 2026
Announcement on 2025 Annual Profit Distribution Plan
April 28, 2026
Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026
April 27, 2026
Announcement on Using Some Temporarily Idle Self-owned Funds for Cash Management
April 10, 2026
Announcement on Resignation of Secretary of the Board of Directors
March 17, 2026
Announcement on Preliminary Earnings Estimate for 2025
February 27, 2026
Announcement on Receiving Notice of Litigation Filing from China Securities Regulatory Commission
February 6, 2026
Earnings Preannouncement for 2025
January 30, 2026
Announcement on Conducting Foreign Exchange Hedging Business
January 16, 2026
Announcement on Reply to Letter of Inquiry from Shanghai Stock Exchange
January 7, 2026
Announcement on Voluntary Disclosure of Signing Strategic Cooperation Framework Agreement
January 6, 2026
Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2025
December 26, 2025
Announcement on Election of Employee Representative Director
December 25, 2025
Announcement on Voluntary Disclosure of Obtaining Medical Device Registration Certificate
December 23, 2025
Announcement on Voluntary Disclosure of Obtaining Medical Device Registration Certificate by Wholly-owned Subsidiary
December 15, 2025
Notice on Convening the 2nd Extraordinary General Meeting in 2025
December 9, 2025
Announcement on the Change in the Shareholding of the Controlling Shareholder, Actual Controller and Chairman and Persons Acting in Concert reaching an Integral Multiple of 1%, and the Results of Shareholding Reduction by the Chairman, and Partial Senior Management Members and Key Technical Personnel
December 8, 2025
Announcement on Vesting Results in the 2nd Vesting Period of the 2023 Restricted Stock Incentive Plan (1st Batch) and Shares Listing
November 27, 2025
Announcement on Convening the Q3 2025 Performance Briefing
November 25, 2025
关于控股股东、实际控制人兼董事长及其一致行动人权益变动触及1%整数倍的提示性公告
November 18, 2025
Announcement on Selection of the Manufacturing Industry Single Crown Enterprises
November 5, 2025
Announcement on the Achievements of Vesting Conditions in the 2nd Vesting Period of the 2023 Restricted Stock Incentive Plan
October 29, 2025
Announcement on Convening the 2025 Semi-annual Performance Briefing
September 18, 2025
Announcement on Voluntary Disclosure of Receipt of Notification for Grant of Invention Patent Rights
September 9, 2025
Announcement on Voluntary Disclosure of Obtaining IVDR CE Certificate
September 5, 2025
Special Report on Semi-annual Deposit and Actual Use of Raised Funds in 2025
August 25, 2025
Announcement on Shareholding Reduction Plan of the Controlling Shareholder, Actual Controller and Chairman, and Partial Senior Executives and Key Technical Personnel
August 18, 2025
Announcement on Implementation of Dividend Distribution for 2024
June 20, 2025
Announcement on Obtaining China Patent Award
June 8, 2025
Announcement on Resolution of the 2024 Annual General Meeting
May 26, 2025
Announcement on Adding Provisional Proposal at 2024 Annual General Meeting
May 15, 2025
Announcement on Resignation of Independent Director after Six-Year Term and Election of New Independent Director and Members of the Board Committees
May 14, 2025
Announcement on Changing the Registered Capital and Amending the Articles of Association
April 24, 2025
Announcement on Resolutions of the 1st Extraordinary General Meeting in 2025
March 31, 2025
Announcement on Early Return of Raised Funds Temporarily Used to Supplement Working Capital
March 28, 2025
Announcement on Vesting Results and Share Listing of Reserved Part (2nd Batch) in 2022 Restricted Stock Incentive Plan during the 2nd Vesting Period
March 26, 2025